| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
AcromegalyPegvisomantCushing s syndromeCardiovascular riskSomatostatin analogs| 1 | 2000 | Modern approaches to treating acromegaly. | 
| + | - | nl | QJM 93(1):1-6 (2000) |
| 2 | 2000 | Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective. | 
| + | - | nl | Clin Invest Med 23(3):172-87 (2000) |
| 3 | 2009 | Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation. | 
| + | - | nl | BMC Endocr Disord 9():20 (2009) Moore DJ |
| 4 | 2010 | Acromegaly: a review of current medical therapy and new drugs on the horizon. | 
| + | - | nl | Neurosurg Focus 29(4):E15 (2010) Fleseriu M |
| 5 | 2010 | Pharmacological management of acromegaly: a current perspective. | 
| + | - | nl | Neurosurg Focus 29(4):E14 (2010) Manjila S |
| 6 | 2010 | Radiation treatment strategies for acromegaly. | 
| + | - | nl | Neurosurg Focus 29(4):E12 (2010) Rowland NC |
| 7 | 2010 | The role of stereotactic radiosurgery in the multimodal management of growth hormone-secreting pituitary adenomas. | 
| + | - | nl | Neurosurg Focus 29(4):E11 (2010) Stapleton CJ |
| 8 | 2004 | Pharmacological approach to the treatment of acromegaly. | 
| + | - | nl | Neurosurg Focus 16(4):E3 (2004) Ezzat S |
| 9 | 2004 | Systemic complications of acromegaly: epidemiology, pathogenesis, and management. | 
| + | - | nl | Endocr Rev 25(1):102-52 (2004) Colao A |
| 10 | 2005 | Simple detection of trace Pb2+ by enrichment on cerium phosphate membrane filter coupled with color signaling. | 
| + | - | nl | Analyst 130(11):1537-42 (2005) Suzuki TM |
| 11 | 1962 | Acromegaly: a review of 100 cases. | 
| + | - | nl | Can Med Assoc J 87(-):1106-9 (1962) |
| 12 | 2008 | A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. | 
| + | - | nl | Eur J Endocrinol 159(2):89-95 (2008) Holdaway IM |
| 13 | 2003 | Pegvisomant: an advance in clinical efficacy in acromegaly. | 
| + | - | nl | Eur J Endocrinol 148 Suppl 2():S27-32 (2003) Stewart PM |
| 14 | 1997 | Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature. | 
| + | - | nl | Eur Respir J 10(6):1401-4 (1997) |
| 15 | 2008 | A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. | 
| + | - | nl | J Clin Endocrinol Metab 93(8):2957-68 (2008) Murray RD |
| 16 | 2008 | Should we still use glucose-suppressed growth hormone levels for the evaluation of acromegaly? | 
| + | - | nl | J Clin Endocrinol Metab 93(4):1181-2 (2008) Colao A |
| 17 | 2008 | Mortality in acromegaly: a metaanalysis. | 
| + | - | nl | J Clin Endocrinol Metab 93(1):61-7 (2008) Dekkers OM |
| 18 | 2007 | Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis. | 
| + | - | nl | J Clin Endocrinol Metab 92(5):1743-7 (2007) Maison P |
| 19 | 2005 | Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. | 
| + | - | nl | J Clin Endocrinol Metab 90(8):4465-73 (2005) Freda PU |
| 20 | 2005 | Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly. | 
| + | - | nl | J Clin Endocrinol Metab 90(3):1856-63 (2005) Bevan JS |
| 21 | 2004 | Monitoring the response to treatment in acromegaly. | 
| + | - | nl | J Clin Endocrinol Metab 89(11):5289-91 (2004) Clemmons DR |
| 22 | 2003 | Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly. | 
| + | - | nl | J Clin Endocrinol Metab 88(3):963-8 (2003) Ben-Shlomo A |
| 23 | 2002 | Guidelines for acromegaly management. | 
| + | - | nl | J Clin Endocrinol Metab 87(9):4054-8 (2002) |
| 24 | 2002 | Somatostatin analogs in acromegaly. | 
| + | - | nl | J Clin Endocrinol Metab 87(7):3013-8 (2002) |
| 25 | 1998 | Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. | 
| + | - | nl | J Clin Endocrinol Metab 83(10):3419-26 (1998) Swearingen B |
| 26 | 2009 | Acromegaly pathogenesis and treatment. | 
| + | - | nl | J Clin Invest 119(11):3189-202 (2009) Melmed S |
| 27 | 2008 | Acromegaly. | 
| + | - | nl | Orphanet J Rare Dis 3():17 (2008) Chanson P |
| 28 | 2003 | Modern treatment of acromegaly. | 
| + | - | nl | Postgrad Med J 79(930):189-93; quiz 192-4 (2003) Merza Z |
| 29 | 1996 | Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin. | 
| + | - | nl | Protein Sci 5(2):195-203 (1996) |
| 30 | 1987 | Acromegaly update--etiology, diagnosis and management. | 
| + | - | nl | West J Med 146(3):328-36 (1987) |
| 31 | 2008 | Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. | 
| + | - | nl | World J Gastroenterol 14(22):3484-9 (2008) Rokkas T |
| 32 | 1996 | The effect of chronic cocaine exposure during pregnancy on maternal and infant outcomes in the rhesus monkey. | 
| + | - | nl | Neurotoxicol Teratol 18(2):147-54 (1996) Morris P |
| 33 | 2010 | A consensus on criteria for cure of acromegaly. | 
| + | - | nl | J Clin Endocrinol Metab 95(7):3141-8 (2010) |
| 34 | 2010 | Approach to the patient with persistent acromegaly after pituitary surgery. | 
| + | - | nl | J Clin Endocrinol Metab 95(9):4114-23 (2010) |
| 35 | 2010 | Acromegaly without imaging evidence of pituitary adenoma. | 
| + | - | nl | J Clin Endocrinol Metab 95(9):4192-6 (2010) |
| 36 | 2008 | Acromegaly. | 
| + | - | nl | Endocrinol Metab Clin North Am 37(1):101-22, viii (2008) |
| 37 | 2011 | American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update. | 
| + | - | nl | Endocr Pract 17 Suppl 4(-):1-44 (2011) |
| 38 | 2010 | Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. | 
| + | - | nl | Clin Endocrinol (Oxf) 72(2):203-8 (2010) |
| 39 | 2010 | Mortality in patients with pituitary disease. | 
| + | - | nl | Endocr Rev 31(3):301-42 (2010) |
| 40 | 2005 | Etiologic aspects and management of acromegaly. | 
| + | - | nl | Arq Bras Endocrinol Metabol 49(5):626-40 (2005) |
| 41 | 2008 | Somatostatin agonists for treatment of acromegaly. | 
| + | - | nl | Mol Cell Endocrinol 286(1-2):192-8 (2008) |